secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2023-02-01T23:59:59+00:00
Accession:  0001493152-23-003270
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce declares Series A Preferred dividend with 1,000 votes per 0.001 share, tied to reverse split vote
--------------------------------------------------------------------------------

- Board declares dividend of 0.001 Series A Preferred share per common share; record date Feb 13, 2023.
- Each 0.001 of a share carries 1,000 votes; voting limited exclusively to reverse split and adjournment proposals.
- Preferred shares are non-transferable except with common; automatically redeemed if not voted at the meeting.
- Liquidation preference of $0.0001 per share; no dividend or conversion rights; filing of Certificate of Designation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223003270/0001493152-23-003270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223003270/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-003270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer